• Current problems exist within the pharmaceutical and complementary medicine packaging industries allowing for easy access by infants and early primary aged children.
  
  
• Void exists between child-resistant screw-cap bottles and conventional paperboard packaging for the introduction and application of PharmaLoc^TM.
  
  
• Market is primed for the introduction of new tamperproof and child-resistant packaging as a result of varied and extensive negative media focus.
  
  
• PharmaLoc^TM designed to take advantage of the global shift towards blister pack packaging for product efficacy and longevity and of amendments to pharmaceutical packaging requirements.
  
  
• Revenue growth through the commercialisation of PharmaLoc^TM into the global US$57billion pharmaceutical packaging sector and through future sub-licensing rights. (Quoted by industry sources)
  
  
• Screw-cap bottles are an inferior, outdated product with industry recognised design faults.
  
  
• Licensees of PharmaLoc^TM will be well-placed to take advantage of amendments to the Australian and International Therapeutic Goods Acts and packaging requirements.